United States Federal Circuit
Orexo AB v. Actavis Elizabeth LLC, 17-1333
Reversed a judgment that a patent for a pharmaceutical product was invalid on the ground of obviousness. The Federal Circuit concluded that obviousness was not proved by clear and convincing evidence.
Appellate Information
- Decided
- Published 2018/09/10
Judges
- Newman
Court
- United States Federal Circuit